Cell Lysis/Cell Fractionation Market To See Good Future Ahead

on

The cell lysis market is expected to reach USD 3.84 Billion by 2021 from USD 2.35 Billion in 2016 at a CAGR of 10.3%. This market is segmented based on product, type of cell, end-users, and regions.

The global cell lysis market consists of various products that are used for extraction of nucleic material, proteins and other cell content. This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine. High potential growth in emerging markets has opened an array of opportunities for the market. However, high cost of cell-based research and shortage of skilled personnel are hampering the growth of the global market.


Based on product, the cell lysis market is segmented into consumables and instruments. Consumables include reagents and kits, beads, and disposables. Reagents and kits are further classified into enzymes, detergent solutions, and other reagents and kits. The consumables segment is expected to account for the largest share of the market in 2016. High prevalence of diseases and increasing funding for cell-based research will drive the growth of this market segment. The instruments segment comprises sonicators, homogenizers, and other instruments.

Based on type of cell, the market is segmented into mammalian cells, microbial cells, and other cells. The mammalian cells segment is expected to account for the largest share of this market, owing to rising investments by governments and companies for cell-based research.

Based on end-users, the cell lysis market is segmented into research laboratories and institutes, biopharmaceutical and biotechnology companies, and others. The research laboratories and institutes segment is expected to account for the largest share of the market in 2016. Increasing prevalence of diseases and rising government investments will drive the growth of this market.


The major players in this market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), F. Hoffman-La Roche AG (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), QIAGEN N.V. (Netherlands), Qsonica, LLC. (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

Comments

Post a Comment